 Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent clotting.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in UAMS Profiles by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 2 | 4 | | 2023 | 1 | 11 | 12 | | 2022 | 0 | 10 | 10 | | 2021 | 3 | 4 | 7 | | 2020 | 8 | 6 | 14 | | 2019 | 3 | 0 | 3 | | 2018 | 10 | 1 | 11 | | 2017 | 6 | 3 | 9 | | 2016 | 5 | 0 | 5 | | 2015 | 10 | 3 | 13 | | 2014 | 10 | 3 | 13 | | 2013 | 6 | 3 | 9 | | 2012 | 4 | 5 | 9 | | 2011 | 5 | 0 | 5 | | 2010 | 4 | 3 | 7 | | 2009 | 1 | 4 | 5 | | 2008 | 3 | 1 | 4 | | 2007 | 5 | 1 | 6 | | 2006 | 1 | 2 | 3 | | 2005 | 0 | 2 | 2 | | 2004 | 1 | 3 | 4 | | 2003 | 2 | 1 | 3 | | 2002 | 2 | 0 | 2 | | 2001 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1996 | 1 | 1 | 2 | | 1992 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles over the past ten years.
-
Reinhardt SW, Gibson DN, Hsu JC, Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Christen T, Allocco DJ, Freeman JV. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left?Atrial?Appendage Occlusion. J Am Coll Cardiol. 2024 Sep 03; 84(10):889-900.
-
Younes AM, Hashem A, Maraey A, Khalil M, Elzanaty A, Elgendy IY. Outcomes among patients with non-ST-elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample. Catheter Cardiovasc Interv. 2024 Nov; 104(5):928-933.
-
Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 09; 21(9):1677-1683.
-
Thind T, Heye T, Henson C, Reif R, Jensen HK, Kalkwarf KJ, Bhavaraju A, Robertson R, Jenkins A. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients. Am Surg. 2024 Jun; 90(6):1406-1411.
-
Alturkmani H, Uretsky B, Patel S, Albadaineh M, Alqaisi O, Alaiwah M, Cross M, Abbasi D, Rollefson W. Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention. Am J Cardiol. 2024 05 01; 218:63-67.
-
Coylewright M, Holmes DR, Kapadia SR, Hsu JC, Gibson DN, Freeman JV, Yeh RW, Piccini JP, Price MJ, Allocco DJ, Nair DG. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. JACC Cardiovasc Interv. 2023 11 27; 16(22):2708-2718.
-
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.
-
Alharbi A, Mhanna M, Alyosif M, Pena C, Jabr A, Alsughayer A, Alfatlawi H, Safi M, Aldhafeeri A, Patel N, Khuder S, Eltahawy E. Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients. Clin Ther. 2024 01; 46(1):e1-e6.
-
Quinn T, Cholette JM, Pinto MG, Schreiber H, Madden MA, Bennett E, Kolmar A, Poole A, Silva CT, Ehrlich L, Navarro OM, Faustino EVS. Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding. J Thromb Haemost. 2024 01; 22(1):213-224.
-
Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 10 01; 9(10):1390-1400.
-
Kalkwarf KJ, Yang Y, Mora S, Wolf DA, Robertson RD, Holcomb JB, Drake SA. The silent killer: Previously undetected pulmonary emboli that result in death after discharge. Injury. 2023 Nov; 54(11):111016.
-
Konsek H, Mealer C, Skidmore S, Collins M, Tchantchaleishvili V, Rajab TK. A proposed objective scale for extracorporeal membrane oxygenation circuit thrombosis. Clin Transplant. 2023 10; 37(10):e15118.
-
Balakrishna AM, Kalathil RAM, Pusapati S, Atreya A, Mehta A, Bansal M, Aggarwal V, Basir MB, Kochar A, Truesdell AG, Vallabhajosyula S. Comparative Outcomes of Catheter-Directed Thrombolysis Plus Systemic Anticoagulation Versus Systemic Anticoagulation Alone in the Management of Intermediate-Risk Pulmonary Embolism in a Systematic Review and Meta-Analysis. Am J Cardiol. 2023 10 15; 205:249-258.
-
Mavros MN, Johnson LA, Schootman M, Orcutt ST, Peng C, Martin BC. Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery. Ann Surg Oncol. 2023 Sep; 30(9):5522-5531.
-
Heye T, Thind T, Jenkins A, Reif R, Jensen HK, Sexton K, Kalkwarf K, Bhavaraju A. Weight-Based Dosing for Venous Thromboembolism Prophylaxis in Spinal Trauma Patients Appears Safe. J Surg Res. 2023 10; 290:209-214.
-
Kar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Am Heart J. 2023 10; 264:123-132.
-
Desai R, Mondal A, Prasad A, Vyas A, Jain A, Rupareliya C, Shah M, Paul T, Kumar G, Sachdeva R. Concurrent Cardio-Cerebral Infarctions in COVID-19: A Systematic Review of Published Case Reports/Series. Curr Probl Cardiol. 2023 Oct; 48(10):101814.
-
Bhatia K, Ladd LM, Carr KH, Di Napoli M, Saver JL, McCullough LD, Hosseini Farahabadi M, Alsbrook DL, Hinduja A, Ortiz Garcia JG, Sabbagh SY, Jafarli A, Divani AA. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines. Curr Neurol Neurosci Rep. 2023 05; 23(5):235-262.
-
Lancaster I, Sethi V, Patel D, Tamboli C, Pacer E, Steinhoff J, Mizrahi M, Willinger A. Antithrombotics and Gastrointestinal Prophylaxis: A Systematic Review. Cardiol Rev. 2024 Nov-Dec 01; 32(6):528-537.
-
Sherard C, Bisbee C, Konsek H, Kang L, Turek JW, Rajab TK. Partial Heart Transplantation in Adult Cardiac Surgery. Innovations (Phila). 2023 Mar-Apr; 18(2):126-131.
-
Salehin S, Muhammad S, Rasmussen P, Mai S, Safder Z, Hasan SM, Ghani HA, Zhang Y, Salehin S, Kuo YF, Chatila K, Khalife W, Sewani A. A comparison of Atrial Fibrillation Detection Strategies After Ischemic Stroke-A Retrospective Study. Curr Probl Cardiol. 2023 Mar; 48(3):101515.
-
Inanc IH, Cilingiroglu M, Iliescu C, NInios V, Matar F, Ates I, Toutouzas K, Hermiller J, Marmagkiolis K. Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease. Cardiovasc Revasc Med. 2023 Feb; 47:76-85.
-
Scheuermann A, Liegl M, Simpson P, Branchford B, Malec L. Safety and Efficacy of Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Pediatric Oncology Patients. J Pediatr Hematol Oncol. 2023 01 01; 45(1):e65-e69.
-
Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, Shah ZI, Shenoy C, Spinler SA, Vallurupalli S, Lip GYH. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 10 11; 146(15):e205-e223.
-
Thalambedu N, Al Hadidi S. Thromboprophylaxis in multiple myeloma. Leuk Lymphoma. 2022 12; 63(12):2807-2815.
-
Bennett E, Delgado-Corcoran C, Pannucci CJ, Wilcox R, Heyrend C, Faustino EV. Outcomes of Prophylactic Enoxaparin Against Venous Thromboembolism in Hospitalized Children. Hosp Pediatr. 2022 06 01; 12(6):617-625.
-
Mhanna M, Beran A, Al-Abdouh A, Jabri A, Al-Aaraj A, Sajdeya O, Abuhelwa Z, Khokher W, Bhuta S, Burmeister CJ, Eltahawy EA. Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk. Curr Probl Cardiol. 2022 Sep; 47(9):101269.
-
Burmeister C, Ghazaleh S, Beran A, Patel NJ, Khokher W, Bhuta S, Mhanna M, Eltahawy E, Assaly R. Head-to-head Comparison Between Direct Oral Anticoagulants and Vitamin K Antagonists for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis. Curr Probl Cardiol. 2023 Aug; 48(8):101232.
-
Lippitt MH, Johnson ES, Frost AS, Thompson SD, Kashi PK, Beavis AL, Fader AN, Ferriss JS, Stone RL, Wethington SL. Optimizing Perioperative Venous Thromboembolism Chemoprophylaxis on a Gynecologic Oncology Service. J Am Coll Surg. 2022 08 01; 235(2):306-314.
-
Stonko DP, Betzold RD, Azar FK, Edwards J, Abdou H, Elansary NN, Gerling KA, White J, Feliciano DV, DuBose JJ, Morrison JJ. Postoperative antiplatelet and/or anticoagulation use does not impact complication or reintervention rates after vein repair of arterial injury: A PROOVIT study. Vascular. 2023 Aug; 31(4):777-783.
-
Hermann RP, Rockey DC, Suzuki A, Merz M, Tillmann HL. A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development. Aliment Pharmacol Ther. 2022 04; 55(8):1028-1037.
-
Vallurupalli S, Sharma T, Al'Aref S, Devabhaktuni SR, Dhar G. Left Atrial Appendage Closure: An Alternative to Anticoagulation for Stroke Prevention in Patients with Kidney Disease. Kidney360. 2022 02 24; 3(2):396-402.
-
Curtis HJ, MacKenna B, Walker AJ, Croker R, Mehrkar A, Morton C, Bacon S, Hickman G, Inglesby P, Bates C, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson E, Hulme W, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wong AY, Forbes H, Parry J, Hester F, Harper S, Douglas I, Smeeth L, Goldacre B. OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic. Open Heart. 2021 11; 8(2).
-
Yaghi S, Henninger N, Giles JA, Leon Guerrero C, Mistry E, Liberman AL, Asad D, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Furie KL, Keyrouz SG, Nouh A, de Havenon A, Khan M, Smith EE, Gurol ME. Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study. J Neurol Neurosurg Psychiatry. 2021 10; 92(10):1062-1067.
-
Devabhaktuni SR, Mounsey JP. Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: PRO. Kidney360. 2021 09 30; 2(9):1405-1408.
-
Briggler R, Matherne E, Johnson C, Boehmer K. Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy. J Pharm Pract. 2022 Oct; 35(5):811-816.
-
Carneiro T, Dashkoff J, Leung L, Nobleza COS, Marulanda-Londono E, Hathidara M, Koch S, Sur N, Boske A, Voetsch B, Daneshmand A, Shulman J, Curiale G, Greer DM, Romero JR, Anand P, Cervantes-Arslanian AM. Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19. J Stroke Cerebrovasc Dis. 2021 07; 30(7):105789.
-
Rech MA, Masic D, Hammond DA. Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding. West J Emerg Med. 2021 Feb 26; 22(2):163-169.
-
Kelley KM, Galvagno SM, Wallis M, Mazzeffi MA, Deatrick K, Betzold R, Scalea T, Menaker J. Tracheostomy in Patients on Venovenous Extracorporeal Membrane Oxygenation: Is It Safe? Am Surg. 2021 Aug; 87(8):1292-1298.
-
Mavros MN, Coburn NG, Davis LE, Zuk V, Hallet J. Risk of venous thromboembolism in patients with elevated INR undergoing hepatectomy: an analysis of the American college of surgeons national surgical quality improvement program registry. HPB (Oxford). 2021 07; 23(7):1008-1015.
-
Rettenmaier LA, Garg A, Limaye K, Leira EC, Adams HP, Shaban A. Management of Ischemic Stroke Following Left Ventricular Assist Device. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105384.
-
Nwajei F, Anand P, Abdalkader M, Andreu Arasa VC, Aparicio HJ, Behbahani S, Curiale G, Daneshmand A, Dasenbrock H, Mayo T, Mian A, Nguyen T, Ong C, Romero JR, Sakai O, Takahashi C, Cervantes-Arslanian AM. Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105412.
-
Omecene NE, Kishk OA, Lardieri AB, Walker LK, Bhutta AT. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation. ASAIO J. 2020 Sep/Oct; 66(9):1042-1047.
-
Nissen AP, Sandhu HK, Perlick AP, Wong VL, Smith TA, Smeds MR, Saqib NU, Martin GH, Miller CC, Charlton-Ouw KM. Heparin-bonded versus standard polytetrafluoroethylene arteriovenous grafts: A Bayesian perspective on a randomized controlled trial for comparative effectiveness. Surgery. 2020 Dec; 168(6):1066-1074.
-
Salah HM, Naser JA, Calcaterra G, Bassareo PP, Mehta JL. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection. Am J Cardiol. 2020 11 01; 134:155-157.
-
Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke. 2020 09; 51(9):2724-2732.
-
Yaghi S, Trivedi T, Henninger N, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Liberman AL, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Leon Guerrero CR, Khan M, Nouh A, Mistry E, Keyrouz S, Furie K. Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk. Ann Neurol. 2020 10; 88(4):807-816.
-
Corona LE, Singhal U, Hafez K, Herrel LA, Kaffenberger SD, Montgomery JS, Morgan TM, Weizer AZ, Qin Y, Ambani SN. Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy. Urol Oncol. 2020 10; 38(10):797.e1-797.e6.
-
Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. 2020 Jul; 29(7):104888.
-
Randhawa MS, Vishwanath R, Rai MP, Wang L, Randhawa AK, Abela G, Dhar G. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 04 01; 3(4):e202175.
-
Bhalla V, Lamping OF, Abdel-Latif A, Bhalla M, Ziada K, Smyth SS. Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous Thromboembolism. Am J Med. 2020 09; 133(9):1074-1081.e8.
-
Karakala N, Juncos LA. Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation. Clin J Am Soc Nephrol. 2020 05 07; 15(5):704-706.
-
Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res. 2020 03; 187:103-112.
-
Greenberg JW, Goff ZD, Mooser AC, Wittgen CM, Smeds MR. Acute Limb Ischemia Secondary to Patent Foramen Ovale-Mediated Paradoxical Embolism: A Case Report and Systematic Review of the Literature. Ann Vasc Surg. 2020 Jul; 66:668.e5-668.e10.
-
Bhogal S, Mukherjee D, Bagai J, Truong HT, Panchal HB, Murtaza G, Zaman M, Sachdeva R, Paul TK. Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials. Cardiovasc Hematol Disord Drug Targets. 2020; 20(1):3-15.
-
Kamran S, Akhtar N, George P, Singh R, Imam Y, Salam A, Babu B, Burke P, Own A, Vattoth S, Perkins J, Parray A, Qadri S, Hamid T. Embolic Pattern of Stroke Associated with Cardiac Wall Motion Abnormalities; Narrowing the Embolic Stroke of Undetermined Source Category. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104509.
-
Sanvicente CT, Ghahramani A, Ustaoglu M, Lee D, Razeghinejad MR. Effect of Anticoagulants and Surgeon-Related Factors on Short-term Outcomes of Laser Peripheral Iridotomy. Ophthalmol Glaucoma. 2019 Jul - Aug; 2(4):204-209.
-
Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. J Cardiovasc Pharmacol Ther. 2019 09; 24(5):428-434.
-
Patel DM, Patel MV, Patel AD, Kaklotar JC, Patel GR, Patel MM. Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin. Curr Drug Saf. 2019; 14(3):246-248.
-
Pouncey DL, Hartman JH, Moore PC, Dillinger DJ, Dickerson KW, Sappington DR, Smith ES, Boysen G, Miller GP. Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients. Blood Coagul Fibrinolysis. 2018 Nov; 29(7):602-612.
-
Bigelow AM, Flynn-O'Brien KT, Simpson PM, Dasgupta M, Hanson SJ. Multicenter Review of Current Practices Associated With Venous Thromboembolism Prophylaxis in Pediatric Patients After Trauma. Pediatr Crit Care Med. 2018 09; 19(9):e448-e454.
-
Mehl SC, Bonasso PC, Dassinger MS. Gallbladder varices in a pediatric patient after roux-en-Y gastric bypass. J Pediatr Surg. 2018 Dec; 53(12):2511-2513.
-
Taggart NW, Gordon BM, Morgan GJ, Goldstein BH. Variation in Anticoagulation Practices in the Congenital Cardiac Catheterization Lab: Results of a Multinational PICES Survey. Pediatr Cardiol. 2019 Jan; 40(1):53-60.
-
Ren X, Evangelista-Leite D, Wu T, Rajab TK, Moser PT, Kitano K, Economopoulos KP, Gorman DE, Bloom JP, Tan JJ, Gilpin SE, Zhou H, Mathisen DJ, Ott HC. Metabolic glycan labeling and chemoselective functionalization of native biomaterials. Biomaterials. 2018 11; 182:127-134.
-
Bhalla V, Abdel-Latif A, Bhalla M, Ziada K, Williams MV, Smyth SS. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients. Am J Cardiol. 2018 10 01; 122(7):1236-1243.
-
Ghannam M, Chugh A, Dillon P, Alyesh D, Kossidas K, Sharma S, Coatney J, Atreya A, Yokokawa M, Saeed M, Cunnane R, Ghanbari H, Latchamsetty R, Crawford T, Jongnarangsin K, Bogun F, Pelosi F, Morady F, Oral H. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial. Heart Rhythm. 2018 11; 15(11):1642-1647.
-
Margolick J, Dandurand C, Duncan K, Chen W, Evans DC, Sekhon MS, Garraway N, Griesdale DEG, Gooderham P, Hameed SM. A Systematic Review of the Risks and Benefits of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury. Can J Neurol Sci. 2018 07; 45(4):432-444.
-
Corwin HL, Shander A. Conjecture and Fact: Prothrombin Complex Concentrates for Bleeding With Vitamin K Antagonists. Crit Care Med. 2018 06; 46(6):1020-1022.
-
Jain N, Reilly RF. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2019 02 07; 14(2):278-287.
-
Mack JM, Richter GT, Crary SE. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphat Res Biol. 2018 06; 16(3):278-281.
-
Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A, Belbase R, Ayan M, Traina M, Alla V, Del Core M. Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke. Am J Cardiol. 2018 06 01; 121(11):1393-1399.
-
Banayan JM, Scavone BM, Mhyre JM. Consensus Statement on Pregnant Women Receiving Thromboprophylaxis: An Essential Tool to Guide Our Management. Anesth Analg. 2018 03; 126(3):754-756.
-
Ashfaq A, Soroya MS, Iyengar A, Federman M, Reemtsen BL. Heparin-Coated Grafts Reduce Mortality in Pediatric Patients Receiving Systemic-to-Pulmonary Shunts. Pediatr Cardiol. 2018 Mar; 39(3):473-477.
-
Rizo-Topete L, Juncos LA. [Anticoagulaci?n en terapia de reemplazo renal continua]. Gac Med Mex. 2018; 154(Supp 1):S61-S71.
-
Przybyla B, Pinom?ki A, Pet?j? J, Joutsi-Korhonen L, Strandberg K, Hillarp A, ?hlin AK, Ruutu T, Volin L, Lassila R. Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD - A longitudinal study. PLoS One. 2017; 12(12):e0190007.
-
Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Weiss JP. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke. J Cardiovasc Electrophysiol. 2018 02; 29(2):221-226.
-
Battle B, Sexton KW, Fitzgerald RT. Understanding the Value of Repeat Head?CT in Elderly Trauma Patients on Anticoagulant?or?Antiplatelet Therapy. J Am Coll Radiol. 2018 02; 15(2):319-321.
-
Shunkwiler SM, Pham HP, Wool G, Ipe TS, Fang DC, Biller E, Treml A, Weiss J, Baron BW, Berg M. The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review. J Clin Apher. 2018 Jun; 33(3):371-379.
-
Kaatz S, Mahan CE, Nakhle A, Gunasekaran K, Ali M, Lavender R, Paje DG. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants. Curr Cardiol Rep. 2017 10 24; 19(12):124.
-
Ludwig DR, Austin MJ, Wallace AN, Kamran M, Kansagra AP, Osbun JW, Cross DT, Moran CJ. Isolated Internal Carotid Artery Thrombus and Cerebral Infarction in a Patient with Necrotizing Pancreatitis: Case Report. J Stroke Cerebrovasc Dis. 2018 Jan; 27(1):e1-e4.
-
Pritchard ER, Murillo JR, Putney D, Hobaugh EC. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer. J Oncol Pharm Pract. 2019 Jan; 25(1):52-59.
-
Wadhwa V, Trivedi PS, Ryu RK, Lessne ML. Increasing Anticoagulation Use Among Inpatients Receiving Inferior Vena Cava Filters. Am J Med. 2017 Aug; 130(8):e373-e374.
-
Connor MJ, Karakala N. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients. Adv Chronic Kidney Dis. 2017 07; 24(4):213-218.
-
Barnette DA, Johnson BP, Pouncey DL, Nshimiyimana R, Desrochers LP, Goodwin TE, Miller GP. Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. Drug Metab Dispos. 2017 09; 45(9):1000-1007.
-
Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis. 2017 Aug; 11(8):203-213.
-
Saad M, Nairooz R, Rashed A, Abdelaziz HK, Mentias A, Abbott JD. Bivalirudin versus heparin in women undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials. Cardiovasc Revasc Med. 2017 Sep; 18(6):418-424.
-
Iyengar A, Hung ML, Asanad K, Kwon OJ, Jackson NJ, Reemtsen BL, Federman MD, Biniwale RM. Association Between Hematologic and Inflammatory Markers and 31 Thrombotic and Hemorrhagic Events in Berlin Heart Excor Patients. Pediatr Cardiol. 2017 Apr; 38(4):770-777.
-
El-Menyar A, Asim M, Jabbour G, Al-Thani H. Clinical implications of the anatomical variation of deep venous thrombosis. Phlebology. 2018 Mar; 33(2):97-106.
-
Casserly EA, Rogers SE, Keisner SV. Lack of interaction between enzalutamide and warfarin in a metastatic castration-resistant prostate cancer patient. J Oncol Pharm Pract. 2017 Jan; 23(1):68-70.
-
Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis. J Stroke Cerebrovasc Dis. 2016 Sep; 25(9):2215-21.
-
Mitma AA, Varghese JG, Witt D, Zarich SW. Stroke and a valvular lesion in a patient with stage IV non-small cell lung cancer. BMJ Case Rep. 2016 May 31; 2016.
-
Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61.
-
Karakala N, Tolwani A. We Use Heparin as the Anticoagulant for CRRT. Semin Dial. 2016 07; 29(4):272-4.
-
Sen P, Kundu A, Sardar P, Chatterjee S, Nairooz R, Amin H, Aronow WS. Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis. Am J Cardiovasc Drugs. 2016 Feb; 16(1):33-41.
-
Bardes JM, Turner J, Bonasso P, Hobbs G, Wilson A. Delineation of Criteria for Admission to Step Down in the Mild Traumatic Brain Injury Patient. Am Surg. 2016 Jan; 82(1):36-40.
-
Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Artif Organs. 2016 Jan; 40(1):80-5.
-
Ayoub K, Nairooz R. Duration of Triple Therapy: A Clinical Question Remains Unanswered. Clin Cardiol. 2015 Dec; 38(12):777.
-
Joy PS, Kumar G, Guddati AK, Bhama JK, Cadaret LM. Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients. Am J Cardiol. 2016 Jan 15; 117(2):240-4.
-
Shewale AR, Johnson JT, Li C, Nelsen D, Martin BC. Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2015 Dec; 24(12):2845-53.
-
Kraleti S. Budd-Chiari Syndrome in a patient with Multiple Hypercoagulopathies. J Ark Med Soc. 2015 Oct; 112(6):90-1.
-
Nairooz R, Ayoub K, Sardar P, Payne J, Almomani A, Pothineni NV, Shailesh F, Aronow WS, Mukherjee D. Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis. Can J Cardiol. 2016 06; 32(6):814-23.
-
Limaye K, Abla AA. We Will Use Antiplatelets As Our First Choice for Prevention of Stroke Recurrence in Cervical Arterial Dissection After Reading CADISS--Will You? World Neurosurg. 2015 Nov; 84(5):1182-4.
-
Pothineni NV, Bahia A, Gobal F, Ahmed Z, Uretsky BF, Hakeem A. "DVT" of the Heart: A "Novel" Treatment for an Old Problem. JACC Cardiovasc Interv. 2015 Aug 24; 8(10):e165-e166.
-
Ayoub K, Marji M, Nairooz R. Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention. Am J Cardiol. 2015 Sep 01; 116(5):828-9.
-
Katragadda L, Murphy MC, Harris NS, Wilkerson G, Bazydlo LA, Zumberg MS. Steps to diagnosis of a case of surreptitious intake of one of the newer direct oral anticoagulants: a case report and literature review. Blood Coagul Fibrinolysis. 2015 Jul; 26(5):574-6.
-
Marmagkiolis K, Lendel V, Cilingiroglu M. Endovascular management of pacemaker-induced brachio-axillo-subclavian venous chronic total occlusion. J Interv Card Electrophysiol. 2015 Oct; 44(1):87-8.
-
Nairooz R, Sardar P, Amin H, Chatterjee S, Helmy T, Naidu SS. Short- and long-term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/IIIA inhibitors: A meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2015 Sep; 86(3):364-75.
-
Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015; 187:426-9.
-
Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. Int J Cardiol. 2015; 187:345-53.
-
Pemberton JD, MacIntosh PW, Zeglam A, Fay A. Naphazoline as a confounder in the diagnosis of carotid artery dissection. Ophthalmic Plast Reconstr Surg. 2015 Mar-Apr; 31(2):e33-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|